03:37 AM EDT, 05/29/2025 (MT Newswires) -- Mark L. Jacobson, Chief Operating Officer, on May 27, 2025, sold 40,673 shares in Axsome Therapeutics ( AXSM ) for $4,232,636. Following the Form 4 filing with the SEC, Jacobson has control over a total of 5,783 common shares of the company, with 5,783 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1579428/000095017025078552/xslF345X05/ownership.xml